Biotech

All Articles

Vertex, beaten through AATD again, goes down 2 resources on throw away pile

.Vertex's attempt to alleviate an uncommon hereditary illness has actually attacked another misfortu...

Vir gains 3 T-cell engagers coming from Sanofi, gives up 25% of staff

.Vir Medical's second-quarter profits record wasn't short of big headlines. The firm welcomed a tria...

Galapagos stops briefly CAR-T tissue therapy litigation over Parkinsonism case

.Galapagos has stopped application in a test of a BCMA-directed CAR-T tissue therapy, pumping the br...

James Wilson leaving behind Penn to launch two brand new biotechs

.After more than 30 years, gene treatment trailblazer James Wilson M.D., Ph.D., is actually leaving ...

3 biotechs try to trump the summer heat energy through losing team

.As biotechs seek to switch a fresh page in August, at the very least 3 firms have actually lost per...

venBio lifts $528M for fifth life scientific researches VC fund

.Expert financial backing organization venBio has lifted another half a billion dollars to invest in...

Otsuka pays for $800M for Jnana and its clinical-stage PKU medicine

.Otsuka Pharmaceutical has gotten Boston-based Jnana Therapies for $800 million so the Eastern biote...

FibroGen lays off 75% people personnel as resource fails 2 even more tests

.FibroGen is radically reorganizing its company, laying off 75% of its U.S. staff and also ceasing f...

Tracon winds down weeks after injectable PD-L1 prevention fall short

.Tracon Pharmaceuticals has made a decision to relax procedures full weeks after an injectable invul...

Ideaya bags choice on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually wagering $400 thousand in biobucks that a bispecific antibody-drug c...